The Shelf by the Tills: What Britain's Over-the-Counter Sleep Aids Can and Cannot Do

It is a familiar scene. The kitchen clock reads ten past three, the kettle is on for the second time, and somewhere in a bathroom cabinet there is a box bought in hopeful haste. Britain's pharmacies and supermarkets sell an unusually wide range of sleep products, and the packaging is designed to be reassuring. What the labels cannot easily convey is how varied the products are in licensing status, in evidence, and in the kind of sleep problem they might plausibly address.

This article is not a set of recommendations. It is a map of the shelf, drawn from the way these products are regulated in the UK and from what the published research actually shows.

Three tiers of permission

Products sold without prescription in the UK fall into distinct legal categories, and the category tells you something useful before you read a single claim on the front of the box.

General Sales List (GSL) items can be sold in any shop, including supermarkets and petrol stations. Pharmacy (P) medicines must be sold under the supervision of a pharmacist, who is expected to ask a question or two. Traditional Herbal Registrations (THR) are a separate scheme run by the Medicines and Healthcare products Regulatory Agency (MHRA); they permit claims based on long-standing traditional use rather than on demonstrated efficacy in clinical trials.

That last point is worth pausing on. A THR logo is a mark of safety and quality assurance, not proof that the product does what the buyer hopes. It means the herb has been used in this way for a qualifying period and that the product meets manufacturing standards. It does not mean a randomised trial has shown it shortens the time it takes to fall asleep.

Antihistamines: a side effect repackaged

The sedating antihistamines sold for sleep — diphenhydramine, promethazine and doxylamine — were not designed for insomnia. Drowsiness is an adverse effect of a drug developed for allergy, and the sleep products are, in effect, that side effect sold on purpose.

Do they work? Modestly, in some people, and largely in the short term. Pooled analyses of diphenhydramine suggest a small reduction in the time taken to fall asleep compared with placebo, with the effect shrinking as the trials become more rigorous. Tolerance develops quickly with regular use, which is one reason the products are labelled for occasional use only.

The more serious consideration is the morning after. Residual sedation can persist for hours, and the anticholinergic action of these drugs is associated with confusion and falls in older adults; observational work has also raised questions about long-term cognitive associations, though causation has not been established. Anyone driving, operating machinery or responsible for young children should think carefully before taking one at midnight. Alcohol compounds the sedation considerably.

Herbal registrations: tradition is not a trial

Valerian is the best-known herbal sleep ingredient in the UK and appears in proprietary blends under a THR. The clinical picture is mixed. Trials exist, but they are typically small, short, and inconsistent in the preparation used — valerian root extract and valerian tincture are not interchangeable, and doses vary widely between studies. Some show benefit; others show nothing distinguishable from placebo.

Hops, passionflower, lavender and lemon balm appear in blends with thinner evidence still. This does not make them harmful, and many people report genuine benefit. It does mean the honest position is that the evidence is uncertain rather than encouraging.

The melatonin confusion

Melatonin occupies an odd place in the British market. Licensed melatonin products are prescription-only medicines in the UK, which surprises many people who have bought it freely abroad or online. Imported supplements are widely available through websites, sometimes in doses far above anything a clinician would prescribe, and the legal position for the individual buyer is not straightforward. The MHRA has been consulted on reclassification more than once without a change to the prescription-only default for licensed products.

Where melatonin is prescribed, it is typically for specific indications such as jet lag or circadian rhythm disorders, and usually for time-limited periods. It is not a general-purpose sleeping tablet, and it does not work in the way most people assume: it shifts timing rather than switching sleep on.

Blends, minerals and the placebo margin

Magnesium, glycine, CBD and a growing assortment of 'night-time' formulations sit largely outside medicines regulation. As food supplements they are not permitted to make medicinal claims, so the wording on the packet tends to gesture rather than assert. The trial evidence is generally preliminary.

None of this means the products are inert in experience. Insomnia is highly responsive to expectation, and the ritual of a warm drink and a tablet at a fixed time is itself a behavioural intervention of sorts. Trials of sleep aids consistently show large placebo responses, which is precisely why uncontrolled testimonials are unreliable and why the double-blind comparison matters.

Dependence, and the slow creep of habit

The physical dependence risk with over-the-counter antihistamines is low compared with prescription hypnotics, but psychological dependence is real and under-discussed. A person who cannot travel without a box, or who has taken half a tablet nightly for two years, has developed a habit that may now be part of the problem rather than the solution. Rebound insomnia on stopping is common and is often misinterpreted as proof that the product was needed.

When the shelf stops being the answer

Short-lived sleeplessness around stress, travel or illness is ordinary. Persistent insomnia — difficulty sleeping on three or more nights a week for three months or more, with daytime consequences — is a clinical problem with an evidence-based first-line treatment, and it is not a tablet. Cognitive behavioural therapy for insomnia (CBT-I) is recommended by NICE as the initial intervention for chronic insomnia in adults, and it is available through NHS Talking Therapies in many areas, sometimes via digital programmes commissioned by local integrated care boards.

A GP appointment is worth booking if sleep has been disrupted for more than a few weeks, if daytime functioning is affected, if low mood or anxiety is present, or if snoring, witnessed pauses in breathing or overwhelming daytime sleepiness suggest sleep apnoea. It is also worth booking if you are taking an over-the-counter sleep aid most nights, or if you are combining products.

Pharmacists are a genuinely useful first stop and will flag interactions with antidepressants, antihistamines taken for allergy, and alcohol. What they cannot do is diagnose the reason sleep has gone. That conversation belongs elsewhere — and it is usually more productive than another box.